FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, specifically to a fibrous haemostat composition, which is able to safely, gradually and completely decompose in a human or animal body in about 30 days, and, as a result, can be used by medical professionals to stop bleeding and promote healing both after and during surgery.
EFFECT: degradable haemostat composition is disclosed.
33 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
DEGRADABLE HAEMOSTAT COMPOSITION | 2014 |
|
RU2682717C2 |
COMPOSITION FOR WOUND BANDAGES | 2016 |
|
RU2775940C2 |
HEMOSTATIC AGENT BASED ON CHITOSAN | 2023 |
|
RU2807862C1 |
LOCAL HEMOSTATIC AGENT | 2023 |
|
RU2807892C1 |
COMPOSITION FOR TEMPORARY CONTROL OF BLEEDING | 2023 |
|
RU2819603C1 |
METHOD OF OBTAINING HEMOSTATIC AGENT BASED ON CHITOSAN | 2023 |
|
RU2806364C1 |
COMPOSITION FOR WOUND TREATMENT AND PRODUCTS ON ITS BASIS | 2011 |
|
RU2467767C1 |
COMPOSITION FOR WOUND DRESSINGS | 2016 |
|
RU2748124C2 |
COMPOSITION FOR WOUND DRESSINGS | 2016 |
|
RU2748184C2 |
HEMOSTATIC AGENT BASED ON CHITOSAN AEROGEL | 2020 |
|
RU2743425C1 |
Authors
Dates
2019-03-19—Published
2014-05-28—Filed